Alpha 2.0
Login Register
» Authors » Rohana J Wright

Rohana J Wright

Explore the profile of Rohana J Wright including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 323
Followers 0
Related Specialties
Endocrinology
General Medicine
Neurology
Top 10 Co-Authors
Anna R Dover
Fraser W Gibb
Roland H Stimson
Mark W J Strachan
Shareen Forbes
Brian M Frier
Ian J Deary
Marcus J Lyall
N Suren Kanagasundaram
Richard Quinton
Published In
Diabet Med
Diabetes Care
Clin Endocrinol (Oxf)
Neuropsychology
BMJ Open Diabetes Res Care
Affiliations
Soon will be listed here.
Recent Articles
1.
Androgen Deficiency, Associations and Survival of Men With Stage 4 and 5 Chronic Kidney Disease: A Cohort Study
De Silva N, Quinton R, de Silva N, Jayasena C, Barbar B, Boot C, et al.
Clin Endocrinol (Oxf) . 2025 Jan; PMID: 39866014
No abstract available.
2.
Omnipod 5 outcomes comparing Dexcom G6 and Freestyle Libre 2 plus users in adults with type 1 diabetes
Stimson R, Dover A, Lyall M, Kyle C, Wright R, McRobert G, et al.
Diabet Med . 2024 Nov; 42(3):e15465. PMID: 39497535
No abstract available.
3.
Outcomes after 1 year in adults using Omnipod 5: Real-world data from a UK diabetes centre
Stimson R, Strachan M, Dover A, Wright R, Forbes S, McRobert G, et al.
Diabet Med . 2024 Oct; 41(12):e15453. PMID: 39392870
No abstract available.
4.
Change in glycated haemoglobin in adults with type 2 diabetes on basal-bolus insulin regimens following commencement of Freestyle Libre use
Dover A, Wright R, Forbes S, Strachan M, Stimson R, Gibb F
Diabetes Obes Metab . 2024 Oct; 27(1):419-421. PMID: 39387171
No abstract available.
5.
Androgen Deficiency, Associations and Survival of Men With Stage 4 and 5 Chronic Kidney Disease: A Cohort Study
De Silva N, Quinton R, de Silva N, Jayasena C, Barbar B, Boot C, et al.
Clin Endocrinol (Oxf) . 2024 Oct; 102(2):190-195. PMID: 39370720
Objectives: Anaemia is a key cause of morbidity in chronic kidney disease (CKD). Androgen deficiency (AD) in males can contribute to anaemia of all causes, including in CKD. We sought...
6.
Associations between glucagon prescribing, hospital admissions for hypoglycaemia and continuous glucose monitoring metrics in adults with type 1 diabetes
Stimson R, Dover A, Strachan M, Wright R, Lyall M, Jeeyavudeen M, et al.
J Diabetes Complications . 2023 Jul; 37(9):108561. PMID: 37499292
Aims: To assess features associated with glucagon prescribing and hospital admissions with hypoglycaemia in type one diabetes. Methods: Observational study of 4462 adults. Outcome measures were features associated with glucagon...
7.
Changes in continuous glucose monitoring metrics and predictors of improvement 12 months after conversion from Freestyle Libre to Freestyle Libre 2
Stimson R, Dover A, Strachan M, Wright R, Forbes S, Gibb F
Diabet Med . 2023 May; 40(11):e15130. PMID: 37151106
Aims: We sought to assess whether conversion from Freestyle Libre to Freestyle Libre 2 (with low and high glucose alert functions) was associated with improved glucose metrics. Research Design And...
8.
Interest in hybrid closed loop is high across the socioeconomic spectrum despite current inequalities in provision in a large UK diabetes centre
Dover A, Ritchie S, Wright R, McMurray E, Strachan M, Stimson R, et al.
Diabet Med . 2023 Feb; 40(5):e15058. PMID: 36723227
No abstract available.
9.
Substantial HbA1c Reduction Following Intermittent-Scanning Continuous Glucose Monitoring Was Not Associated With Early Worsening of Retinopathy in Type 1 Diabetes
Linton K, Stimson R, Dover A, Forbes S, Madill K, Annoh R, et al.
J Diabetes Sci Technol . 2021 Feb; 16(4):921-928. PMID: 33605149
Background: Early worsening of diabetic retinopathy (EWDR) was observed in the intensively treated arm of the Diabetes Control and Complications Trial (DCCT) before long-term benefits accrued. We sought to assess...
10.
Socioeconomic deprivation, technology use, C-peptide, smoking and other predictors of glycaemic control in adults with type 1 diabetes
Dover A, Strachan M, McKnight J, Stimson R, Mackenzie S, Lyall M, et al.
Diabet Med . 2020 Oct; 38(3):e14445. PMID: 33128811
Aims: Intensive glycaemic control is associated with substantial health benefits in people with type 1 diabetes. We sought to examine clinical and demographic factors associated with meeting glycaemic targets in...